Search research articles
Contact Us
Filters
Showing results (161-170 of 256) with videos related to
Page
of 26
Sort By:
Blood Advances
|
July 21, 2019
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
J B Langenhorst, C van Kesteren, E M van Maarseveen, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation
|
February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
L G M Daenen, L E van der Wagen, E F Bonneville, et al.
Cell Reports
|
May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Haematologica
|
May 7, 2011
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
Suzanne van Dorp, Henrike Resemann, Liane te Boome, et al.
Haematologica
|
August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party
Francesco Onida, Ronald Brand, Anja van Biezen, et al.
Bone Marrow Transplantation
|
May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation
Mohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Cytotherapy
|
February 28, 2024
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, et al.
The Lancet. Haematology
|
December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis
Jurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Journal of Translational Medicine
|
August 4, 2016
Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation
Julia Drylewicz, Ingrid M M Schellens, Rogier Gaiser, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 256) with videos related to
Sort By:
Page
of 26
Blood Advances
|
July 21, 2019
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
J B Langenhorst, C van Kesteren, E M van Maarseveen, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation
|
February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
L G M Daenen, L E van der Wagen, E F Bonneville, et al.
Cell Reports
|
May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Haematologica
|
May 7, 2011
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
Suzanne van Dorp, Henrike Resemann, Liane te Boome, et al.
Haematologica
|
August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party
Francesco Onida, Ronald Brand, Anja van Biezen, et al.
Bone Marrow Transplantation
|
May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation
Mohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Cytotherapy
|
February 28, 2024
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, et al.
The Lancet. Haematology
|
December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis
Jurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Journal of Translational Medicine
|
August 4, 2016
Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation
Julia Drylewicz, Ingrid M M Schellens, Rogier Gaiser, et al.
Page
of 26